Skip to main content

Table 1 Relevant clinicopathological features of all studied breast cancer patients

From: Her2/EGFR-PDGFR pathway aberrations associated with tamoxifen response in metastatic breast cancer patients

Characteristics

N = 157 (%)

Age

 Mean: 51.63 ± 10.5

  < 50

76 (48.4)

  ≥ 50

81 (51.6)

Tumor size

 ≤ 5 cm

131 (83.4)

 > 5 cm

26 (16.6)

TNM staging-T

 T1

13 (8.3)

 T2

104 (66.2)

 T3

40 (25.5)

Lymph nodes

 N0

30 (19.1)

 N1

51 (32.5)

 N2

51 (32.5)

 N3

25 (15.9)

Grade

 1

11(7)

 2

112 (71.3)

 3

34 (21.65)

ER

 Negative

49 (31.2)

 Positive

108 (68.8)

PR

 Negative

79 (50.3)

 Positive

78 (49.7)

HER2

 Negative

99 (63.1)

 Positive

58 (36.9)